In a field plagued by frequent controversy, the American Cancer Society (ACS) claims to have taken a major step forward to provide transparency in how justified it is in recommending cancer screening tests. It blames oncologists with a conflict of interest...what would you expect from an organization that depends on income from big pharma and the mammography industry. They also plan to assess the need for the PSA test, colonoscopies, and mammograms. They suggest that overtesting leads to too many biopsies and over diagnosis.
Just a year ago, one of their senior physicians was interviewed by the NY Times and was quoted saying the same things as in the above. However, within 4 hours he was pressured into recanting his comments. Pressure from the ACS was the reason for the "change of heart."